Immix Biopharma, Inc.
corporate_fare Company Profile
Immix Biopharma, Inc. (NASDAQ:IMMX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for IMMX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Immix Biopharma Files $750M Shelf Registration, Signaling Substantial Future Dilution
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$29.44M
Diluted EPS
-$0.89
Op. Cash Flow
-$23.93M
Free Cash Flow
-$24.66M
Operating Income
-$29.96M
Cash & Equivalents
$93.93M
Debt / Equity
0.00×
Shares Outstanding
52.95M sh
Source: 10-K · filed 2026-03-27 · accession 0001493152-26-013298
show_chartPrice Chart
Loading chart...
feed IMMX - Filings & News (Page 2)
IMMX
Jan 09, 2026, 5:28 PM EST
Price at Filing:
$4.78
Real-time Price:
$7.21
Change:
+$2.43 (+51%)
Market Cap:
$583.335M